Jordi Badia

With a successful business career in life sciences that spans over twenty years, Jordi is a seasoned international executive experienced in running biopharmaceutical businesses globally. Prior to becoming Founding Partner at Orphan Now Consulting, Jordi spent seven years at Alexion Pharmaceuticals as its European commercial head and general manager. He played a critical role in the setting up and expansion of Alexion and the launch of Soliris® (eculizumab) in the EMEA Region. Jordi joined Alexion after working as the head of global marketing at Almirall, where he managed the company’s product portfolio globally and led the establishment of its commercial operations in Europe and Latin America. Additionally, Jordi worked at Abbott Laboratories’ global headquarters in Chicago, where he drove the international launch of Synagis® (palivizumab) in his position as global brand leader. Before working for Abbott, he spent eight years at Novartis, initially as a corporate financial controller at its headquarters in Basel, Switzerland, and later as Novartis’ China business development director at its Beijing office.

Jordi received an MBA from the Kelley School of Business at Indiana University at Bloomington. He was recognized for his international academic excellence with a Kelley’s Global Achievement Award. Jordi earned a license of law from Universidad de Barcelona School of Law.